Bruce Wendel, Executive VP Corporate Development at Abraxis BioScience, Inc. (ABII), sold 797 shares at $35.42 ($28K) on 2009-11-10, disclosed to the SEC on 2009-11-12.
Open-market sale of $28k ABII by Executive VP Corporate Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.